HK1162616A1 - Methods for determining the risk of prenatal complications - Google Patents

Methods for determining the risk of prenatal complications

Info

Publication number
HK1162616A1
HK1162616A1 HK12103231.9A HK12103231A HK1162616A1 HK 1162616 A1 HK1162616 A1 HK 1162616A1 HK 12103231 A HK12103231 A HK 12103231A HK 1162616 A1 HK1162616 A1 HK 1162616A1
Authority
HK
Hong Kong
Prior art keywords
risk
determining
methods
prenatal
complications
Prior art date
Application number
HK12103231.9A
Other languages
English (en)
Chinese (zh)
Inventor
Howard Cuckle
Kypros Nicolaides
Tarja Ahola
Leona Poon
Original Assignee
華萊克合股公司
胎兒醫學基金會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40901463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1162616(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 華萊克合股公司, 胎兒醫學基金會 filed Critical 華萊克合股公司
Publication of HK1162616A1 publication Critical patent/HK1162616A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/515—Angiogenesic factors; Angiogenin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Vascular Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK12103231.9A 2008-01-25 2012-04-02 Methods for determining the risk of prenatal complications HK1162616A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2377608P 2008-01-25 2008-01-25
US2589008P 2008-02-04 2008-02-04
US6004808P 2008-06-09 2008-06-09
US6073208P 2008-06-11 2008-06-11
PCT/US2009/032062 WO2009094665A1 (en) 2008-01-25 2009-01-26 Methods for determining the risk of prenatal complications

Publications (1)

Publication Number Publication Date
HK1162616A1 true HK1162616A1 (en) 2012-08-31

Family

ID=40901463

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12103231.9A HK1162616A1 (en) 2008-01-25 2012-04-02 Methods for determining the risk of prenatal complications

Country Status (9)

Country Link
US (5) US8647832B2 (de)
EP (3) EP2245180B1 (de)
CN (2) CN102216468B (de)
AU (1) AU2009206243B2 (de)
CA (2) CA2967508C (de)
ES (2) ES2523220T3 (de)
HK (1) HK1162616A1 (de)
PL (1) PL2245180T3 (de)
WO (1) WO2009094665A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002210403A1 (en) * 2000-10-20 2002-04-29 Como Biotech Aps Pregnancy-associated plasma protein-a2 (papp-a2)
EP2245180B1 (de) * 2008-01-25 2014-06-18 PerkinElmer Health Sciences, Inc. Verfahren zur bestimmung des risikos pränataler komplikationen
US8876714B2 (en) * 2010-02-22 2014-11-04 Wallac Oy Systems and methods for assessing risk of chromosomal disorders
AU2011340630B2 (en) * 2010-12-06 2017-01-19 Mycartis Nv Biomarkers and parameters for hypertensive disorders of pregnancy
IN2014CN04326A (de) * 2011-12-15 2015-09-04 Pronota Nv
CN104380104B (zh) * 2012-04-24 2021-03-30 西门子医疗保健诊断公司 先兆子痫筛查法
WO2014036440A2 (en) * 2012-08-30 2014-03-06 Ansh Labs Llc Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia
US20140273025A1 (en) * 2013-03-15 2014-09-18 Wallac Oy System and method for determining risk of pre-eclampsia based on biochemical marker analysis
CN103278633B (zh) * 2013-04-28 2014-11-19 成都中医药大学 一种孕妇流产史筛查试剂盒
CN103207274B (zh) * 2013-04-28 2015-02-25 成都中医药大学 一种胎儿7号染色体异常疾病的筛查试剂盒
CN103235133B (zh) * 2013-04-28 2014-11-19 成都中医药大学 一种胎儿9号染色体异常疾病的筛查试剂盒
CN103235142B (zh) * 2013-04-28 2015-04-15 成都中医药大学 一种孕妇初次妊娠筛查试剂盒
WO2015009615A1 (en) * 2013-07-15 2015-01-22 Vanderbilt University Methods for the production of collagen iv
US10281475B2 (en) * 2014-03-27 2019-05-07 Wayne State University Systems and methods to identify and treat subjects at risk for obstetrical complications
EP3143409A2 (de) * 2014-05-16 2017-03-22 Cézanne S.A.S. Insulinähnliches frühplazentapeptid (pro-epil)
US10656163B2 (en) 2014-09-02 2020-05-19 Wallac Oy Method for determining risk of pre-eclampsia
WO2016042202A1 (en) 2014-09-17 2016-03-24 Wallac Oy Method for determining the risk of preterm birth
WO2016095789A1 (en) * 2014-12-15 2016-06-23 The Chinese University Of Hong Kong Detecting bacterial taxa for predicting preterm birth after clinical intervention
WO2016191793A1 (en) 2015-06-02 2016-12-08 Medvet Science Pty Ltd Methods for screening for fetal trisomies
KR101817180B1 (ko) * 2016-01-20 2018-01-10 이원다이애그노믹스(주) 염색체 이상 판단 방법
EP3682250A4 (de) 2017-09-13 2021-03-03 Progenity, Inc. Präeklampsie-biomarker sowie zugehörige systeme und verfahren
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor
CN111370121B (zh) * 2020-02-21 2024-07-30 杭州市妇产科医院 早孕期非整倍体产前筛查标志物预测妊娠期高血压疾病的风险模型建立方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812432D0 (en) * 1998-06-09 1998-08-05 Queen Mary & Westfield College Predictive test
GB0026823D0 (en) * 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
PT2305301E (pt) * 2002-07-19 2015-04-21 Beth Israel Hospital Métodos de tratamento de pré-eclâmpsia
US20050255114A1 (en) * 2003-04-07 2005-11-17 Nuvelo, Inc. Methods and diagnosis for the treatment of preeclampsia
GB0317476D0 (en) * 2003-07-25 2003-08-27 Wright David E Methods and apparatus for screening for chromosomal abnormalities
US20060094039A1 (en) * 2004-09-20 2006-05-04 Ron Rosenfeld Diagnosis of fetal aneuploidy
ATE519109T1 (de) * 2004-12-21 2011-08-15 Univ Yale Präeklampsie-diagnose
GB0600916D0 (en) * 2006-01-17 2006-02-22 Perkinelmer Instr Las Inc detecting and predicting pre-eclampsia
EP2245180B1 (de) * 2008-01-25 2014-06-18 PerkinElmer Health Sciences, Inc. Verfahren zur bestimmung des risikos pränataler komplikationen

Also Published As

Publication number Publication date
EP2245180A4 (de) 2011-06-08
AU2009206243A1 (en) 2009-07-30
CA2967508C (en) 2020-02-25
CA2713229A1 (en) 2009-07-30
EP2657697A3 (de) 2014-02-19
CN102216468A (zh) 2011-10-12
US8673582B2 (en) 2014-03-18
US20140113320A1 (en) 2014-04-24
US20160305950A1 (en) 2016-10-20
AU2009206243B2 (en) 2014-10-02
US8932823B2 (en) 2015-01-13
ES2587077T3 (es) 2016-10-20
US20140113319A1 (en) 2014-04-24
EP2245180A1 (de) 2010-11-03
CA2967508A1 (en) 2009-07-30
EP2245180B1 (de) 2014-06-18
EP3109322A1 (de) 2016-12-28
ES2523220T3 (es) 2014-11-24
US20100304412A1 (en) 2010-12-02
PL2245180T3 (pl) 2015-03-31
US8647832B2 (en) 2014-02-11
CN103969455A (zh) 2014-08-06
WO2009094665A1 (en) 2009-07-30
CN102216468B (zh) 2014-06-11
CA2713229C (en) 2017-07-11
EP2657697A2 (de) 2013-10-30
EP2657697B1 (de) 2016-06-08
US20130344503A1 (en) 2013-12-26
CN103969455B (zh) 2016-08-24

Similar Documents

Publication Publication Date Title
HK1162616A1 (en) Methods for determining the risk of prenatal complications
ZA201101970B (en) Multispecific antibodies
EP2359275A4 (de) Einflussbeurteilung
EP2351777A4 (de) Anti-muc1-antikörper
HK1153538A1 (en) Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events -1
GB2462829B (en) Measurement method
EP2147309A4 (de) Verfahren für den nachweis von präeklampsie
GB2471221B (en) Methods
EP2344667A4 (de) Verfahren zur haplotypbestimmung mittels haplodissektion
GB0818650D0 (en) Methods
EP2389104A4 (de) Identifikation der gefährdung eines fötus während der arbeit
EP2318508A4 (de) Bestimmung der integrität einer rna
EP2263086A4 (de) Biomarker
GB0811360D0 (en) Methods
PL2183985T3 (pl) Określanie ścieżki pochodzenia
EP2275814A4 (de) A-beta-oligomer-messverfahren
IL213510A (en) Biomarker
GB2457797B (en) Covariance based face association
EP2265641A4 (de) Biomarker
EP2208986A4 (de) Verfahren zur bestimmung von autoinducer-2
EP2340037A4 (de) Verfahren zur schätzung des tgf-beta-pegels in einer zusammensetzung
PL2288920T3 (pl) Sposób określania zakażenia Trichinella
TWI348657B (en) Determination method of edge direction
EP2231868A4 (de) Assay-verfahren
GB0819405D0 (en) Assay method